Investment Bank for the Healthcare Sector

With insights and relationships throughout the healthcare ecosystem, our team excels at securing ideal partners to create value for our clients.

Connect with us

45+

healthcare transactions in 2023

>65%

healthcare sell-side M&A transactions with private equity clients in 2023

Providing Quality Outcomes for Healthcare Clients

Healthcare is one of the most dynamic and complex areas in the global economy. Healthcare leaders who want to capitalize on rapid changes in science, regulation, technology and therapeutics benefit from the expertise of investment banking advisors with relevant experience and a keen focus on their unique goals. Our passion for healthcare and our focus on creating shareholder value for our clients has made us one of the fastest growing investment banking advisors for healthcare sector.

Sector Focus

Provider Services

Home Healthcare
Physician Services
Outpatient Services
Pharmacy Services

Pharmaceutical & Lab Services

Contract Research Organizations
Analytical Lab Services
Clinical Lab Services
Contract Manufacturing
Medical Communications

Process Outsourcing

Hospital Outsourcing
Revenue Cycle Management
Employer Health Services
Healthcare IT

Medical Devices & Outsourcing

Devices & Equipment
Products & Supplies
Medical Components
Contract Design / Manufacturing

Life Sciences

Diagnostic Instruments
Research Equipment
Lab Supplies
Consumables & Kits

Managed Care

Health Plans
Third-Party Administration
Benefits Management
Payor Outsourced Services

Perspectives & Publications

What Price is Right? Trends and Opportunities for Private Equity in Pharma Market Access

The cost of developing new drugs is staggering. Among the top 20 global biopharmas, the average cost of developing a candidate from discovery through clinical trials to market was approximately… Read More

Investment Opportunities in Pharma: A Data-Driven Exploration of CDMO Appeal

The report discusses the current state of the contract development and manufacturing organization (CDMO) market within the pharmaceutical industry, emphasizing the increased interest from private equity (PE) investors. The pharmaceutical… Read More

Scrip Asks…What Does 2024 Hold for Biopharma?

James West, Managing Director in Lincoln’s Healthcare Group, recently discussed his expectations for the biopharma market in 2024 as part of Scrip’s series. Part One – Business Strategy and Leadership… Read More

HealthInvestor | CMA Launches Review of Vet Sector

Originally posted by HealthInvestor on September 7, 2023. The Competition and Markets Authority (CMA) has begun reviewing UK veterinary services to uncover how well the market is working for pet… Read More

Lincoln’s expertise in healthcare services and with private companies, combined with their process execution capabilities, proved to be invaluable. At all times the Lincoln team acted as a trusted advisor and truly understood the needs of an owner-entrepreneur."
Avo Minasyan
Co-Founder and CEO, TNH
Healthcare

American & European Healthcare Group Heads

Meet our Senior Team with Healthcare Expertise